Please assess the completion status of the following clinical trial:

Trial Title: Switching to Duloxetine From Other Antidepressants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female outpatients of at least 18 years of age, who meet criteria for Major Depressive Disorder (MDD)~* Currently non- or only partially-responsive to an SSRI antidepressant after at least 5 weeks of treatment~Exclusion Criteria include:~* Current primary Axis I disorder other than MDD~* Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorders~* Patients judged to be at serious suicidal risk.~* Serious medical illness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).